Mirum Pharmaceuticals, Inc. (MIRM)

NASDAQ: MIRM · Real-Time Price · USD

93.27

+1.38 (1.50%)

At close: Jan 21, 2026, 4:00 PM EST

93.20

-0.07 (-0.08%)

Pre-market: Jan 22, 2026, 5:47 AM EST

Mirum Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Jan '26 Jan 21, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Market Capitalization	4,821	1,985	1,376	719	486	511	Upgrade
Market Cap Growth	134.62%	44.25%	91.51%	47.79%	-4.80%	-7.70%	Upgrade
Enterprise Value	4,764	2,018	1,378	535	299	380	Upgrade
Last Close Price	93.27	41.35	29.52	19.50	15.95	17.46	Upgrade
PS Ratio	9.76	5.89	7.38	9.32	25.41	-	Upgrade
PB Ratio	16.39	8.80	5.53	5.06	4.04	2.97	Upgrade
P/TBV Ratio	80.14	-	-	8.65	4.79	2.97	Upgrade
P/FCF Ratio	108.77	212.71	-	-	-	-	Upgrade
P/OCF Ratio	107.86	192.25	-	-	-	-	Upgrade
EV/Sales Ratio	10.10	5.99	7.39	6.95	15.62	-	Upgrade
EV/FCF Ratio	107.49	216.27	-	-	-	-	Upgrade
Debt / Equity Ratio	1.09	1.41	1.24	0.02	0.02	0.02	Upgrade
Debt / FCF Ratio	7.19	34.05	-	-	-	-	Upgrade
Asset Turnover	0.65	0.51	0.37	0.24	0.07	-	Upgrade
Inventory Turnover	4.16	3.65	3.38	3.50	-	-	Upgrade
Quick Ratio	3.01	2.83	4.07	2.72	3.76	12.56	Upgrade
Current Ratio	3.31	3.10	4.45	2.94	3.91	12.80	Upgrade
Return on Equity (ROE)	-15.81%	-37.08%	-83.65%	-103.46%	-57.47%	-68.29%	Upgrade
Return on Assets (ROA)	-3.60%	-8.31%	-13.65%	-25.33%	-40.48%	-33.64%	Upgrade
Return on Capital Employed (ROCE)	-6.70%	-16.10%	-19.50%	-45.50%	-68.80%	-46.90%	Upgrade
Earnings Yield	-0.86%	-4.43%	-11.88%	-18.88%	-17.27%	-20.22%	Upgrade
FCF Yield	0.92%	0.47%	-5.16%	-16.76%	-27.31%	-17.48%	Upgrade
Buyback Yield / Dilution	-4.69%	-16.23%	-20.31%	-12.07%	-20.08%	-119.84%	Upgrade

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q